|
Obese patients with or without diabetes who took a minimum dosage of the appetite-suppressing glucagon-like peptide-1 hormone for at least 20 weeks lost more weight than people in control groups from a review of 25 studies in the British Medical Journal. Researchers also noted improvements in blood pressure and total cholesterol levels in GLP-1-treated patients. BMJ, Jan, 2012 |
